Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000029879 | SCV000052534 | likely pathogenic | Maturity-onset diabetes of the young type 2 | 2011-08-18 | criteria provided, single submitter | curation | Converted during submission to Likely pathogenic. |
Clinical Genomics, |
RCV002371785 | SCV002605289 | likely pathogenic | Maturity onset diabetes mellitus in young | criteria provided, single submitter | research | Potent mutations in GCK gene is associated with poor secretion of insulin. Its associated with milder forms of diabetes, which can be controlled by diet . However, there is no sufficient evidence to ascertain the significance of rs193922295 in MODY, yet. | |
Ambry Genetics | RCV002371785 | SCV002626051 | pathogenic | Maturity onset diabetes mellitus in young | 2016-04-14 | criteria provided, single submitter | clinical testing | The c.393delC pathogenic mutation, located in coding exon 4 of the GCK gene, results from a deletion of one nucleotide at nucleotide position 393, causing a translational frameshift with a predicted alternate stop codon (p.D132Tfs*8). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |